MXPA02005506A - Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo. - Google Patents
Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.Info
- Publication number
- MXPA02005506A MXPA02005506A MXPA02005506A MXPA02005506A MXPA02005506A MX PA02005506 A MXPA02005506 A MX PA02005506A MX PA02005506 A MXPA02005506 A MX PA02005506A MX PA02005506 A MXPA02005506 A MX PA02005506A MX PA02005506 A MXPA02005506 A MX PA02005506A
- Authority
- MX
- Mexico
- Prior art keywords
- parasite
- cloning
- sequencing
- diagnostic
- therapeutic
- Prior art date
Links
- 244000045947 parasite Species 0.000 title abstract 4
- 239000003226 mitogen Substances 0.000 title abstract 2
- 102000006534 Amino Acid Isomerases Human genes 0.000 title 1
- 108010008830 Amino Acid Isomerases Proteins 0.000 title 1
- 238000010367 cloning Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000012163 sequencing technique Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Un metodo para evitar o inhibir la infeccion por un parasito o virus in vivo comprende administrarle a un humano que necesite del mismo un mitogeno parasito o virus en una cantidad sub-mitogenica suficiente para inducir una respuesta inmune protectora contra el parasito o virus en el humano.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16863199P | 1999-12-03 | 1999-12-03 | |
US22020700P | 2000-07-24 | 2000-07-24 | |
US22111700P | 2000-07-27 | 2000-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02005506A true MXPA02005506A (es) | 2004-09-10 |
Family
ID=27389546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02005506A MXPA02005506A (es) | 1999-12-03 | 2002-06-03 | Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo. |
Country Status (6)
Country | Link |
---|---|
US (6) | US6713617B2 (es) |
EP (1) | EP1240315B1 (es) |
AU (1) | AU2212701A (es) |
BR (1) | BRPI0016129B1 (es) |
MX (1) | MXPA02005506A (es) |
WO (1) | WO2001040449A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2768747B1 (fr) * | 1997-09-19 | 2000-12-01 | Pasteur Institut | Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes |
US6713617B2 (en) * | 1999-12-03 | 2004-03-30 | Institut Pasteur | Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
US7585656B2 (en) | 2003-02-11 | 2009-09-08 | Institute Pasteur | Crystallographic structure of TcPRACA and uses therefor |
MXPA05008535A (es) * | 2003-02-11 | 2006-03-08 | Pasteur Institut | Identificacion y caracterizacion de racemasas, definicion de firmas proteinicas, y una prueba para examinar aminoacido d para seleccionar moleculas capaces de inhibir la actividad de racemasa, especialmente racemasa de prolina. |
US20050119725A1 (en) * | 2003-04-08 | 2005-06-02 | Xingwu Wang | Energetically controlled delivery of biologically active material from an implanted medical device |
US20050155779A1 (en) * | 2003-04-08 | 2005-07-21 | Xingwu Wang | Coated substrate assembly |
BRPI0410975A (pt) | 2003-05-30 | 2006-07-04 | Pasteur Institut | forma cristalina de prolina racemase de trypanosoma cruzi praca (tcpraca), composição, métodos para fabricar uma forma cristalina de tcpraca e para identificar uma substáncia que pode ligar-se à tcpraca e consequentemente afetar a atividade biológica de tcpraca, substáncia, dispositivo para realizar o método, método para projetar uma molécula que afeta a atividade biológica de tcpraca, e, molécula |
US20060118758A1 (en) * | 2004-09-15 | 2006-06-08 | Xingwu Wang | Material to enable magnetic resonance imaging of implantable medical devices |
EP1814995A2 (en) * | 2004-10-27 | 2007-08-08 | North Carolina State University | Lactobacillus acidophilus nucleic acids and uses thereof |
US20090156431A1 (en) * | 2007-12-12 | 2009-06-18 | Si Lok | Methods for Nucleic Acid Mapping and Identification of Fine Structural Variations in Nucleic Acids |
BRPI0915371A2 (pt) * | 2008-07-04 | 2016-10-18 | Inst Rech Developpement Ird | um método para avaliação de proteínas secretadas conservadas |
RU2490634C1 (ru) * | 2012-01-27 | 2013-08-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Тюменская государственная сельскохозяйственная академия" (ФГБОУ ВПО ТГСХА) | Способ диагностики хламидийной инфекции у хряков-производителей |
CN114854728B (zh) * | 2022-05-12 | 2023-11-24 | 云南师范大学 | 一种脯氨酸消旋酶及其制备和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025606A2 (de) * | 1993-04-23 | 1994-11-10 | Sandoz Ltd. | Rekombinante alanin racemase und gapdh aus tolypocladium niveum |
JP3473985B2 (ja) * | 1994-04-26 | 2003-12-08 | 協和醗酵工業株式会社 | D−プロリンの製造法 |
US6713617B2 (en) | 1999-12-03 | 2004-03-30 | Institut Pasteur | Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
JP2005117918A (ja) | 2003-10-14 | 2005-05-12 | Glycomedics Inc | 新規糖鎖プライマー |
-
2000
- 2000-11-30 US US09/725,945 patent/US6713617B2/en not_active Expired - Lifetime
- 2000-12-04 BR BRPI0016129A patent/BRPI0016129B1/pt not_active IP Right Cessation
- 2000-12-04 WO PCT/IB2000/002008 patent/WO2001040449A2/en active Application Filing
- 2000-12-04 EP EP00985729A patent/EP1240315B1/en not_active Expired - Lifetime
- 2000-12-04 AU AU22127/01A patent/AU2212701A/en not_active Abandoned
-
2002
- 2002-06-03 MX MXPA02005506A patent/MXPA02005506A/es active IP Right Grant
-
2003
- 2003-09-16 US US10/662,425 patent/US20050130166A1/en not_active Abandoned
- 2003-09-16 US US10/662,437 patent/US20050090656A1/en not_active Abandoned
-
2006
- 2006-03-17 US US11/378,706 patent/US8168770B2/en not_active Expired - Fee Related
- 2006-03-17 US US11/384,144 patent/US7851603B2/en not_active Expired - Fee Related
- 2006-03-24 US US11/388,474 patent/US7732563B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20060252921A1 (en) | 2006-11-09 |
WO2001040449A3 (en) | 2002-01-10 |
WO2001040449A9 (en) | 2002-11-07 |
US20050130166A1 (en) | 2005-06-16 |
US20040018206A1 (en) | 2004-01-29 |
BRPI0016129B1 (pt) | 2016-07-05 |
US8168770B2 (en) | 2012-05-01 |
WO2001040449A2 (en) | 2001-06-07 |
US7732563B2 (en) | 2010-06-08 |
US20060292596A1 (en) | 2006-12-28 |
US20050090656A1 (en) | 2005-04-28 |
AU2212701A (en) | 2001-06-12 |
US20060292598A1 (en) | 2006-12-28 |
BR0016129A (pt) | 2002-08-20 |
US6713617B2 (en) | 2004-03-30 |
EP1240315A2 (en) | 2002-09-18 |
EP1240315B1 (en) | 2012-06-20 |
US7851603B2 (en) | 2010-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02005506A (es) | Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo. | |
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
EP1728863A3 (en) | C-class oligonucleotide analogs with enhanced immunostimulatory potency | |
IL188362A0 (en) | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals | |
HUP0105400A2 (hu) | Transznazális beviteli immunizálás kitűnően adaptálódó vivőanyagokkal | |
SG156652A1 (en) | Yeast-based therapeutic for chronic hepatitis c infection | |
MXPA05008526A (es) | Metodos y composicion inmunogenica. | |
PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
Habibi et al. | Cytokine gene expression in healing and non‐healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi‐quantitative RT–PCR | |
AU688101B2 (en) | Live vaccine for the treatment of tumour diseases | |
EP1471936A4 (en) | HIV VACCINE AND METHOD OF USE | |
HUP9801266A2 (hu) | Multimer, rekombináns ureázvakcina | |
ZA965586B (en) | Coccidiosis poultry vaccine | |
MXPA03009763A (es) | Vacuna contra el virus de la enfermedad de la fiebre aftosa. | |
WO1999053950A3 (en) | Live vaccines and methods of treatment therewith | |
BR9815496A (pt) | Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório | |
HK1082666A1 (en) | Ihnv g fusion protein for immune stimulation | |
BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
CA2084673A1 (en) | 16 kda surface protein of p.falciparum | |
RU2008128870A (ru) | Иммуностимулирующие нуклеиновые кислоты | |
HUP0200162A2 (hu) | Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása | |
ATE305941T1 (de) | Impfstoff | |
PT1173481E (pt) | Citoquinas inactivas para a imunização |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |